P-188 NF ( DrugBank: - )

---

1 disease

ID	Disease name (Link within this page)	Number of trials
113	Muscular dystrophy	1

113. Muscular dystrophy

---

Clinical trials : 622 /  Drugs : 485 - (DrugBank : 99) / Drug target genes : 59 - Drug target pathways : 168

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03558958 (ClinicalTrials.gov)	August 8, 2018	5/6/2018	Safety and Efficacy of P-188 NF in DMD Patients	An Exploratory, Open-label Study to Assess the Effect of P-188 NF (Carmeseal-MD) on Safety, on Respiratory and Cardiac Dysfunction and on Upper Limb Strength in Non-ambulatory Patients With Duchenne Muscular Dystrophy (DMD)	Duchenne Muscular Dystrophy	Drug: P-188 NF	Phrixus Pharmaceuticals, Inc.	Charley's Fund	Suspended	12 Years	25 Years	Male	10	Phase 2	United States